Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan

NCT05189327 | Unknown

• 1 other identifier: KSSSID-052021
• Study Type: observational
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.

Conditions

Ulcerative Colitis Chronic; Crohn Disease Colon

Keywords

Nonspecific Ulcerative colitis; Crohn Disease; Patient Registry

Outcome Measures

Primary Outcomes (1)

• To study the incidence of NUC and CD in the Republic of Kazakhstan

  To study the incidence of NUC and CD in the Republic of Kazakhstan

  2 years

Secondary Outcomes (3)

• To study the patterns of the course of the disease and the treatment effect

  2 years

• Conduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease

  2 years

• Analysis of the relationship between management strategies and treatment outcomes

  2 years

Study Arms (1)

Patients with diagnosed Nonspecific Ulcerative Colitis and Crohn Disease

All patients with diagnosed Nonspecific Ulcerative Colitis and Crohn Disease in the Republic of Kazakhstan.

Other: No intervention

Interventions

No intervention OTHER

Non-interventional study

Patients with diagnosed Nonspecific Ulcerative Colitis and Crohn Disease

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients with a verified diagnosis of Nonspecific Ulcerative Colitis and Crohn Disease.

You may qualify if:

• Availability of a signed informed consent form; or the presence of a disinterested witness if the patient is unable to examine and sign the consent form due to illiteracy or disability (for example, in the case of blindness);
• The patient has a documented diagnosis of ulcerative colitis or Crohn's disease (endoscopy, histology, if indicated by radiation diagnostics);
• Patients who have applied for treatment or are already taking treatment from a gastroenterologist / coloproctologist, including inpatients;
• Citizenship of the Republic of Kazakhstan (or resides).

You may not qualify if:

• Patient takes part in an interventional clinical trial;
• Patient is unable to follow the schedule of the visits;
• Any condition that the PI believes would prevent a study participant from participating in the study.

Sponsors & Collaborators

• Kazakhstan Scientific Society for Study of intestine diseases: lead
• FERRING Kazakhstan: collaborator

Study Sites (1)

Primary Health Clinic #5

Almaty, Kazakhstan

RECRUITING

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel Diseases; Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases

Study Officials

• Jamilya Kaibullayeva, PhD

  KSSSID

  STUDY DIRECTOR

Central Study Contacts

Jamilya Kaibullayeva, PhD

CONTACT

+77471051195; kaibullaev@mail.ru

Kanat Khazhidinov, M.Sc.

CONTACT

+77074138263; k.khazhidinov@ksssid.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 2 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 29, 2021
• First Posted: January 12, 2022
• Study Start: December 10, 2021
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: January 12, 2022

Record last verified: 2021-12

Data Sharing

• IPD Sharing: Will not share

Locations

KA (1)